RELCOF PE (Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
Pill with imprint RELCOF PE is White, Capsule-shape and has been identified as Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg. It is supplied by Burel Pharmaceuticals, Inc..
RelCof PE is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. RelCof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RELCOF PE
Relcof PE
- Generic Name:
- chlorpheniramine/methscopolamine/phenylephrine
- Imprint:
- RELCOF PE
- Strength:
- chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 35573-0003
More about RelCof PE (chlorpheniramine / methscopolamine / phenylephrine)
- RelCof PE Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: upper respiratory combinations
Consumer resources
Other brands: AH-Chew II
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
